300 mg (6 mL Gabapentin Oral Solution Cup Lid.jpg)
Gabapentin Solution
Product Images NDC 60687-919
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60687-919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Clcr (Gaba Os 1)
This text provides a formula to calculate Creatinine Clearance (CLCr) for female patients based on their age, weight, and serum creatinine levels. The formula involves multiplying the difference between the age in years and 40 by the weight in kilograms, then further multiplying the result by 0.85 and 772. This information can be helpful in determining renal function in female patients.*
Structure (Gaba Os 2)
Figure 1 (Gaba Os 3)
This is information about a clinical trial evaluating the mean pain score over a 4-week dose titration period followed by a 4-week fixed dose period. The study includes a comparison between a placebo group and a group receiving a daily dose of 3600 mg of Gabapentin. Baseline and weekly data points are plotted on the chart.*
Figure 2 (Gaba Os 4)
This text seems to be a comparison of mean pain scores during a dose titration period and a fixed dose period. The study involves the use of a placebo and two different dosages of gabapentin (1800 mg/day and 2400 mg/day) for pain management. The text provides information about the baseline data and the progression of pain scores over the two different periods.*
Figure 3 (Gaba Os 5)
Figure 4 (Gaba Os 6)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
